$12.6 Billion is the total value of Carlyle Group Inc.'s 11 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ZI | Sell | ZoomInfo Technologies Inc | $3,717,627,000 | -19.3% | 60,755,473 | -31.2% | 29.42% | -5.6% |
ATC | Atotech Ltd | $3,711,195,000 | -5.4% | 153,672,703 | 0.0% | 29.37% | +10.6% | |
PPD | PPD Inc | $2,607,267,000 | +1.5% | 55,722,733 | 0.0% | 20.63% | +18.7% | |
OCDX | Sell | Ortho Clinical Diagnostics H | $2,182,599,000 | -28.9% | 118,106,000 | -17.6% | 17.27% | -16.9% |
ONEM | 1Life Healthcare Inc | $275,657,000 | -38.7% | 13,612,681 | 0.0% | 2.18% | -28.4% | |
VTRU | Vitru Ltd | $99,944,000 | -7.0% | 6,246,471 | 0.0% | 0.79% | +8.8% | |
TALO | Talos Energy Inc | $32,020,000 | -12.0% | 2,325,337 | 0.0% | 0.25% | +2.8% | |
SMHI | Seacor Marine Hldgs Inc | $5,315,000 | +5.0% | 1,147,989 | 0.0% | 0.04% | +23.5% | |
ONE | Onesmart Intl Ed Group Ltdsponsored ads | $3,851,000 | -60.2% | 7,860,000 | 0.0% | 0.03% | -53.8% | |
SPNT | SiriusPoint Ltd | $1,198,000 | -8.1% | 129,408 | 0.0% | 0.01% | 0.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Wesco Aircraft Hldgs Inc | 28 | Q4 2019 | 16.8% |
Seacor Marine Hldgs Inc | 22 | Q3 2023 | 1.1% |
Enviva Partners LP | 21 | Q2 2020 | 31.5% |
Enduro Rty Tr | 21 | Q1 2018 | 2.8% |
USA Compression Partners LP | 20 | Q2 2018 | 28.5% |
Pattern Energy Group Inc | 20 | Q3 2018 | 16.2% |
Concord Med Svcs Hldgs Ltd | 19 | Q3 2017 | 1.1% |
Superior Energy Svcs Inc | 19 | Q3 2017 | 0.7% |
Cobalt Intl Energy Inc | 17 | Q1 2017 | 11.0% |
Sequential Brnds Group Inc N | 17 | Q1 2020 | 1.7% |
View Carlyle Group Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Complete Solaria, Inc. | September 22, 2023 | 2,745,879 | 5.7% |
Carlyle Credit Income Fund | September 14, 2023 | 4,785,628 | 41.0% |
eFFECTOR Therapeutics, Inc. | August 18, 2023 | 4,829,891 | 7.8% |
Vera Therapeutics, Inc. | August 02, 2023 | 1,872,764 | 4.2% |
Reneo Pharmaceuticals, Inc. | May 09, 2023 | 2,730,457 | 8.2% |
EXICURE, INC. | April 13, 2023 | 287,137 | 3.4% |
SPRUCE BIOSCIENCES, INC. | February 23, 2023 | 3,734,518 | 9.2% |
Vaxcyte, Inc. | February 10, 2023 | 2,070,724 | 2.6% |
NuCana plc | August 11, 2022 | 3,353,134 | 6.4% |
QuidelOrtho Corp | June 06, 2022 | 12,460,183 | 18.6% |
View Carlyle Group Inc.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
ARS | 2024-04-18 |
DEF 14A | 2024-04-18 |
DEFA14A | 2024-04-18 |
8-K | 2024-04-03 |
PRE 14A | 2024-04-03 |
4 | 2024-04-02 |
SC 13G | 2024-03-29 |
8-K | 2024-03-27 |
4 | 2024-03-05 |
SC 13D/A | 2024-03-05 |
View Carlyle Group Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.